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Introduction: SARS-CoV-2 virus enters human cells via ACE-2 receptors and causes multiple organs dysfunction.
These ACE-2 receptors are in cells surface of human lung, liver, heart, kidney and blood vessels. The expression of
ACE2 receptors in cortical neurons, glial cells and spinal cord cells create nervous system susceptible to SARS-CoV-2
attack and may be a source of different neurological deficits including myelitis in COVID-19 patients.
Method: A 56-year old gentleman diagnosed with COVID-19 pneumonia presented with acute flaccid paralysis (AFM)
of lower limbs, difficulty in sphincter control and urinary retention. MRI head was normal whilst thoracic spine with
contrast demonstrated long continuous abnormal high signal intensity in the ventral horn of the grey matter in the
upper and mid thoracic cord (T4 to T8) with no post contrast enhancement. Lumbar puncture showed CSF pleocytosis
with lymphocytes predominance, high CSF protein and normal CSF sugar.
Result: Clinical presentation of patient, MRI of thoracic spine showed hyperintensity signals in ventral horn of gray
matter and abnormal CSF analysis were suggestive of viral myelitis probable related to COVID-19 infection.
Discussion: Probable hypothesis that SARS-CoV-2 enters neuronal cells by ACE2 receptors, activation of immune
system against virus and hyper-inflammatory response (cytokine storm) that damage blood - brain barrier (BBB) and
enter central nervous system (CNS). Other probable hypothesis might be molecular mimicry of SARS-CoV2 and
neuronal tissues. Another speculation that Corona viruses may invades peripheral nerves terminal then enter the CNS
via a trans-synaptic transfer.
Key words: COVID-19, acute flaccid myelitis, SARS-CoV-2

BACKGROUND: COVID-19 pneumonia caused by severe acute respiratory syndrome corona virus 2 (SARS-CoV-2
virus) was first witnessed in Wuhan, China in December 2019. It has been confirmed that COVID-19 disease is caused
by a new type of enveloped RNA coronavirus B named SARS-CoV-2. Studies have shown that the virus has 79%
similarity with SARS virus [1]. SARS-CoV-2 virus enters the human body through ACE-2 receptors on the surface of
human cells and causes disease. There are ACE-2 receptors in type II alveolar epithelial cells of human lung, so it has
become the main target of SARS-CoV-2 in the pathogenesis of COVID-19 pneumonia [2]. It has been established that
many critically ill patients have multiple organ dysfunctions including lungs, liver, heart, blood vessels and kidney. The
expression of ACE2 receptors in cortical neurons and glial cell create them susceptible to a SARS-CoV-2 attack, which
was the possible source of anosmia and other neurological deficits seen in COVID-19. ACE2 receptors are also
expressed on the surface of spinal cord cells [3]. Probable one hypothesis is that infectious organism was targeted
against by immunologic system which also attacked central nervous system tissue because of structural similarities
between the corona virus cellular wall components and neuronal receptors (molecular mimicry) [4]. Another hypothesis
is that ACE2 receptors were also expressed on the membrane of spinal cord neurons [5], suggesting that SARS-CoV-2
is implicated in AFM by ACE2 receptors on the surface of spinal cord neurons. Another speculation that Corona virus
may invades peripheral nerves terminal then enter the CNS via a trans-synaptic transfer. AFM is a rare acquired spinal
cord disorder that presents with the rapid onset of weakness in one or more limbs. There are diverse pathologies that
affect the spinal cord including trauma, autoimmune, infectious, neoplastic, vascular and hereditary degenerative
diseases. AFM is an estimated incidence of less than one case per one million populations in the United States [6].
Most cases in the United States have occurred in children with a median age of 6 years (range 3 months to 21 years).
There have been also case reports of AFMoutside US including Canada and European countries. The true rate of AFM
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among adults is not known, but it is thought to be extremely rare. There are numerous different pathologies can cause
damage to anterior horn cells, the classic cause of AFP is by poliovirus, presenting as poliomyelitis. As polio has neared
eradication via vaccination, there has been increasing recognition that other viruses may cause AFP, including
enterovirus D68[7]. Acute motor weakness due to anterior horn cell involvement has been reported with many
enterovirus serotypes. These include poliovirus and several nonpolio enteroviruses, such as enterovirus D68 and
enterovirus A71, flaviviruses, West Nile virus and adenoviruses. These viruses target motor neurons in the brainstem
and spinal cord. Furthermore, immune mediated causes of AFP have been identified (anti-myelin oligodendrocyte
glycoprotein [MOG] antibody associated disease) that can be indistinguishable from virally mediated AFM. Standard
testing of patients suspected of AFM includes magnetic resonance imaging (MRI) of the brain, cervical and thoracic
spine with and without contrast, cerebrospinal fluid (CSF) analysis, nasopharyngeal swabs for viral testing (e.g.,
enterovirus PCR), fecal samples for viral testing (e.g. enteroviruses), and serum testing for potential mimics (e.g.,
anti-MOG antibodies). The diagnosis of AFM requires a clinical phenotype that includes acute flaccid weakness and
MRI of the spinal cord that reveals predominantly gray matter involvement. We report a patient with COVID-19
pneumonia who suddenly developed AFP involving lower limbs and urinary retention after initial high fever and
shortness of breathiness suggesting of AFP that could be attacked by SARS-CoV-2.
Case introduction:
A 56-year old gentleman, known of type 2 diabetes mellitus for 4 years and newly discovered with G6PD deficiency
came to emergency department (ED) with complaints of high-grade fever of 38.9°C (102°F), fatigue for four days and
lower limbs weakness and urinary retention for one days. Physician examination showed lower abdominal tenderness,
palpable urinary bladder and bilateral lower limbs weakness. Urinary catheterization yields a urine volume more than
1200 ml, which not reveal any growth on culture. In ED ultrasound KUB requested to rule out obstructive uropathy that
showed urinary bladder was distended, pre-void urine volume of 1327ml, post-void 873ml. Mild enlargement of
prostate 24 ml. Chest X-ray (Fig: 2) showed bilateral infiltrates especially right lower zone and prominent
broncho-vascular markings. Patient admitted on medical floor for evaluation for suspected COVID-19. After 12 hours
of admission, patients developed short of breath, respiratory rate of 36 breaths/ minutes, SpO2- 92% on 5
liter/minutes on face mask oxygen. The test of COVID-19 RNA nasopharyngeal swabs PCR was positive; diagnosed with
Covid-19 pneumonia. He was transferred to COVID-19 tertiary care Hospital for evaluation and treatment. Neurology
team was consulted for evaluation of lower limbs weakness. Neurological examination showed normal higher mental
function. Cranial nerves and extraocular movements were intact. Facial muscle strength was normal and equal
bilaterally. Motor system examination of upper limbs were normal while lower limbs were low muscles tone, muscles
strength of 3/5(MRC) distal and proximal bilaterally. Hyporeflexia at knee and ankle jerk with equivocal plantar
responses. Sensation was intact to all modalities in the upper limbs. There was a subtle sensory level at T6 to pinprick
testing. After admission, routine covid-19 laboratory test was requested. MRI Head was normal while cervical and
thoracic spine with gad: (Fig:1a,b) showed continuous long subtle high signal intensity in the ventral horn of the grey
matter in the upper and mid thoracic cord at T4-to T8 level (arrows in fig1a), with no post IV contrast enhancement;
findings represent viral myelitis. Lumbar puncture was performed showed of CSF pleocytosis with lymphocyte
predominance normal glucose and high protein as shown in Table 1. Patient’s inflammatory markers were elevated as
shown in table 1. Based on the clinical presentation, abnormal CSF and MRI thoracic spine, finding suggestive of acute
flaccid viral myelitis most likely related to SARS-CoV-2 virus. Routine CSF cultures and PCR for viruses and bacteria
were negative. Other viral panels like poliovirus, West Nile virus, Enterovirus, Zika virus did not performed due to
financial constraint of patient. After diagnosis of COVID-19 pneumonia, standard treatment was given as local CDC
recommendation except HCQ due to G6PD deficiency. Patient was treated for acute flaccid myelitis with pulse steroid
and acyclovir according standard dosages. On the 4 day after admission, the patient found in room unresponsive, CPR
started with initial rhythm was asystole, inj: epinephrine, atropine were given, return of spontaneous circulation (ROSC)
achieved but patient was comatose, suspected unstable pulmonary embolism, empirical thrombolytic (rTPA) for
unstable Pulmonary embolism (PE) was given, bedside “point of care” ultrasound (POCUS) exam showed signs of PE
(+ve McConnell’s Sign). Patient again went asystole, CPR done but patient ECG showed flat line and declared dead.
Discussion:
We present a rare case report of acute flaccid myelitis (AFM) in COVID-19 patient. Other similar case reported from
Renmin Hospital of Wuhan University, Wuhan, China. Acute flaccid myelitis may be the one of rare neurological
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manifestation of SARS-Cov2 virus. There was 36% neurological symptoms evidence in a one case series especially in
more severe illness and higher mortality [8]. The neurological complications include acute ischemic or hemorrhagic
stroke, impairment of consciousness, ataxia, seizures, skeletal muscle injury, meningitis, encephalopathy as well as
Guillain Barre Syndrome. One of probable hypothesis that infectious organism was targeted against by immunologic
system which also attacked CNS tissue because of structural similarities between the microbial cellular wall
components and neuronal receptors result of “molecular mimicry” [4]. Another Probable hypothesis that corona virus
may invade peripheral nerve terminals then access to the CNS via a synapse-connected route. The trans-synaptic
transfer has been well documented for other CoVs, such as HEV-67 and avian bronchitis virus [9]. Neurons do have
ACE2 receptors and postmortem pathological studies have detected SARS-Cov1 (by electron microscopy) in some
neurons of patients with SARS-ARDS [10]. Recent study showed that SARS-CoV-2 could enter spinal cord neurons
through ACE2 receptors on the membrane of spinal cord and causes acute myelitis. SARS-Cov2 activates of cytokines
such as interleukin and TNF-alpha (cytokines storm) causes injury to the blood-brain barrier. With increasing damage
to blood-brain barrier, cytokines penetrate the brain parenchyma [11]. With the penetration of blood content into the
brain, viral particles can enter and damage neurons directly.
Conclusion:
This rare case report represents a patient with COVID-19 pneumonia associated with acute flaccid myelitis that was
supported by abnormal MRI spinal cord and CSF findings. Acute flaccid myelitis might be very rear neurological
manifestation of SARS-CoV-2 virus.
Table 1 Blood, biochemical and CSF investigations after admission:
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Fig 1b: Few tiny T2/FLAIR hyperintense foci are seen in
the left frontal white matter, likely minor chronic
microangiopathic changes.
Fig 1a: Axial and sagittal T2 weighted images of MRI of
the dorsal spine, demonstrate subtle continuous long
high signal intensity in the ventral horn of the grey
matter in the upper and mid thoracic cord at T4 to T8
level (arrows), with no post IV contrast enhancement;
findings represent viral myelitis.

Fig 2: evolving infiltrates esp: right lower zone and
prominent bronchovascular markings bilaterally.
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